Description (Abstract)
Sale and transfer of all right, title and interest in tissue factor antagonists, including mouse, chimeric or humanized anti-tissue factor monoclonal antibodies and derived fragments, encoding nucleic acids, expression vectors, plasmids, hybridomas and production cell lines, for acute lung injury (ALI), acute respiratory distress syndrome (ARDS) or sepsis, including the sub-indications of community-acquired pneumonia (CAP), severe avian respiratory syndrome (SARS) and avian flu.
Citation
RoyaltyStat 2005, Asset Purchase and License Agreement, L8584. https://doi.org/10.34675/L8584
Subscription Options
Subscribe to a prepaid package of 150 agreements for 6000 USD. Larger prepaid packages of 250, 500 and 1000 agreements are available.
Please contact us for more information.
Please contact us for more information.
